LRP1B and dementia: These findings suggest that ACE inhibitors may have a neuroprotective effect against β-amyloid neurotoxicity and promote neuronal cell survival in Alzheimer’s disease and/or dementia by upregulating LRP1B, 14-3-3 protein zeta/delta, and calreticulin.